MAPT and Parkinson disease: In the present study, we found no clear evidence to support the hypothesis that tau accumulation considered in isolation is a critical driver of the early development of PDD, with increased 18F-AV-1451 binding in the high and low dementia risk PD groups being found only in subcortical regions that are established sites of off-target binding with this particular tracer.